Study of Adjunctive Ganaxolone Treatment in Children and Young Adults With CDKL5 Deficiency Disorder
Clinical trial NCT03572933 · COMPLETED
Trial details
- NCT number
- NCT03572933
- Sponsor
- Marinus Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-30
- Primary completion
- 2020-07-31
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.